Condition
Hypertrophic Obstructive Cardiomyopathy (HOCM)
Total Trials
6
Recruiting
1
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Unknown2
Active Not Recruiting2
Recruiting1
Not Yet Recruiting1
Clinical Trials (6)
Showing 6 of 6 trials
NCT07150299RecruitingPrimary
Myocardial Perfusion Changes Following Optimal Medical Treatment in Symptomatic Hypertrophic Cardiomyopathy
NCT07120776Not ApplicableNot Yet RecruitingPrimary
Positron Emission Tomography to Assess the Effect of Camzyos on Ischaemia in HOCM: PEACH Trial
NCT07003945Active Not RecruitingPrimary
Clinical Outcomes of PIMSRA Treating for Hypertrophic Obstructive Cardiomyopathy: A Large-Sample Study
NCT06277960Not ApplicableActive Not RecruitingPrimary
Septal Ablation for Obstructive HCM
NCT06078410UnknownPrimary
Neurologic Evaluation of Patients After Transapical Beating-Heart Septal Myectomy
NCT01332162Phase 2UnknownPrimary
CArdiac Desynchronization In Obstructive HCM, CARDIO-HCM
Showing all 6 trials